FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

FOR2240 Scientist Dr. Alexander C. Rokohl was selected for the Cologne Clinician Scientist Program

DOG Rokohl

DOG Rokohl

We are proud to announce that Dr. Alexander C. Rokohl was selected to attend the Cologne Clinician Scientist Program (CCSP) of the Medical Faculty at the University of Cologne.
The outstanding scientific achievements of Dr. Alexander C. Rokohl attracted a lot of attention at national and international scientific meetings and he won several scientific awards including the ESOPRS Richard Collin Junior Award 2018. In his highly ranked publication Dry Anophthalmic Socket Syndrome – Standardized clinical evaluation of symptoms and signs (Rokohl AC et al. – Ocular Surface 2020), Dr. Alexander C. Rokohl and his supervisor Univ.-Prof. Dr. Ludwig M. Heindl were the first in the world who described and defined a new clinical syndrome, the Dry Anophthalmic Socket Syndrome (DASS). The aim of this research in the course of the CCSP is to identify further molecular mechanisms of the DASS and to develop an evidence-based therapy algorithm for this disease.
The Cologne Clinician Scientist Program (CCSP) is a comprehensive, attractive, and sustainable career development program for highly motivated young clinician-scientists who have demonstrated a special talent for scientific work. The CCSP is intended to promote a bidirectional translational approach: from the bench to bedside and back. Additionally, the mentoring during the CCSP provides the participants know-how in career planning, soft skills, as well as in scientific and peer consulting work.
Dr. Alexander C. Rokohl is affiliated with the FOR2240 Project P4 which is supervised and led
by Univ.-Prof. Dr. Ludwig M. Heindl.

Related posts

January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more
November 22, 2022

4th Shanghai-Cologne Scientific Symposium


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck